A Phase I Study of LJM716 in Japanese Patients With Advanced Solid Tumors

NCT01911936 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
12
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Novartis Pharmaceuticals